9911796707
TMI BlogMeril Presents Successful LANDMARK RCT One-Year Results at Prestigious EuroPCR 2025X X X X Extracts X X X X X X X X Extracts X X X X ..... Meril Presents Successful LANDMARK RCT One-Year Results at Prestigious EuroPCR 2025 X X X X Extracts X X X X X X X X Extracts X X X X ..... safety of the Next Gen Myval THV series VAPI, India, May 22, 2025 /PRNewswire/ -- Meril Life Sciences announced one-year results from its pivotal LANDMARK trial, presented during the prestigious Late- ..... X X X X Extracts X X X X X X X X Extracts X X X X ..... Breaking Trial session at EuroPCR 2025, one of the world's premier cardiology conferences held annually in Paris, France. The LANDMARK trial is the first randomized non-inferiority trial comparing the ..... X X X X Extracts X X X X X X X X Extracts X X X X ..... balloon-expandable Myval THV series with other contemporary balloon-expandable Sapien THV series and self-expandable Evolut THV series in patients with symptomatic severe aortic stenosis. The Myval ..... X X X X Extracts X X X X X X X X Extracts X X X X ..... THV series demonstrated non-inferiority to contemporary THVs in terms of 1-year clinical efficacy composite endpoint (Myval THV Series: 13% vs. Contemporary THV: 13.1%, difference: -0.1%, one-sided 9 ..... X X X X Extracts X X X X X X X X Extracts X X X X ..... 5% CI: 3.9%, Pnoninferiority Logo: (Disclaimer: The above press release comes to you under an arrangement with PRNewswire and PTI takes no editorial responsibility for the same.). PTI PWR PWR X X X X Extracts X X X X X X X X Extracts X X X X ..... - Press release - PIB ..... X X X X Extracts X X X X X X X X Extracts X X X X
|
